Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-17-114914
Filing Date
2017-04-07
Accepted
2017-04-07 08:01:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 d362300d425.htm 425 7981
2 GRAPHIC g362300g02g16.jpg GRAPHIC 38117
3 GRAPHIC g362300g93r76.jpg GRAPHIC 77573
  Complete submission text file 0001193125-17-114914.txt   169668
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filed by) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-32157 | Film No.: 17747664
SIC: 2834 Pharmaceutical Preparations